Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan Deng

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Neurocritical Care|November 16, 2018
Expansion-Prone Hematoma: Defining a Population at High Risk of Hematoma Growth and Poor OutcomeQi Li, Yi-Qing Shen, Xiong-Fei Xie, et al.
Annals of Clinical and Translational Neurology|November 27, 2023
Impact of early cognitive impairment on outcome trajectory in patients with intracerebral hemorrhageZuo-Qiao Li, Xiao-Qing Bu, Jing Cheng, et al.
Annals of Hematology|September 18, 2023
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort studyGuangyang Weng, Jingya Huang, Xin He, et al.
Journal of Internal Medicine|October 26, 2022
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemiaGuangyang Weng, Yu Zhang, Guopan Yu, et al.
Journal of the American Heart Association|January 28, 2021
Noncontrast Computed Tomography Markers as Predictors of Revised Hematoma Expansion in Acute Intracerebral HemorrhageWen-Song Yang, Shu-Qiang Zhang, Yi-Qing Shen, et al.
Nano Letters|March 29, 2018
Diatomic Metasurface for Vectorial HolographyZi-Lan Deng, Junhong Deng, Xin Zhuang, et al.
Leukemia & Lymphoma|January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterationsLina Chen, Kathrin Tyryshkin, Alison Moore, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2019
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell TransplantationLi Xuan, Yu Wang, Jia Chen, et al.
Frontiers in Neurology|August 1, 2022
Corrigendum: New Prediction Models of Functional Outcome in Acute Intracerebral Hemorrhage: The dICH Score and uICH ScoreWen-Song Yang, Yi-Qing Shen, Xiao Wei, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Neurocritical Care|November 16, 2018
Expansion-Prone Hematoma: Defining a Population at High Risk of Hematoma Growth and Poor OutcomeQi Li, Yi-Qing Shen, Xiong-Fei Xie, et al.
Annals of Clinical and Translational Neurology|November 27, 2023
Impact of early cognitive impairment on outcome trajectory in patients with intracerebral hemorrhageZuo-Qiao Li, Xiao-Qing Bu, Jing Cheng, et al.
Annals of Hematology|September 18, 2023
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort studyGuangyang Weng, Jingya Huang, Xin He, et al.
Journal of Internal Medicine|October 26, 2022
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemiaGuangyang Weng, Yu Zhang, Guopan Yu, et al.
Journal of the American Heart Association|January 28, 2021
Noncontrast Computed Tomography Markers as Predictors of Revised Hematoma Expansion in Acute Intracerebral HemorrhageWen-Song Yang, Shu-Qiang Zhang, Yi-Qing Shen, et al.
Nano Letters|March 29, 2018
Diatomic Metasurface for Vectorial HolographyZi-Lan Deng, Junhong Deng, Xin Zhuang, et al.
Leukemia & Lymphoma|January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterationsLina Chen, Kathrin Tyryshkin, Alison Moore, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2019
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell TransplantationLi Xuan, Yu Wang, Jia Chen, et al.
Frontiers in Neurology|August 1, 2022
Corrigendum: New Prediction Models of Functional Outcome in Acute Intracerebral Hemorrhage: The dICH Score and uICH ScoreWen-Song Yang, Yi-Qing Shen, Xiao Wei, et al.
Pageof 23